Rhodiola Rosea (3% Rosavins)
Siberian Rhodiola Rosea 3/1 Dry Extract
3.0% Rosavins & 1% Salidroside
The rhizomes of
NutraceuticsRx offers the highest quality Siberian Rhodiola Rosea Root
Extract on the market today.
Rhodiola rosea contains many bioactive compounds, including:
flavonoids, amino acids, polysaccharides and others. The most bioactive
components in Rhodiola rosea are a group of glucosides of cinnamyl
alcohol, primarily rosin, rosavin and rosarin . Another compound, salidroside
is also considered to be valued for bioactivity, and is widely used as a
reference standard for the extract. According to the Russian pharmacopoeia, the
raw Rhodiola rosea must contain a minimum of 0.8% salidroside. There
is a similarity of chemical structures between salidroside and syringin
(eleutheroside B) isolated from Eleutherococcus senticosus.
Pharmacology and clinicals: In Tibet, Rhodiola rosea
is regarded as plateau ginseng. It has stimulative and adaptogenic action to
improve physical and mental work ability; to increase attention span and memory;
to mitigate stress and to increase resistance to the unfavorable effects of
various chemical, physical or biological factors . A Former Soviet Union
military institute has found Rhodiola rosea to be a strengthening tonic
for astronauts in stressful conditions. Research has also confirmed Rhodiola's
antitumor activity, and its ability to inhibit tumor metastasis.
Analytical specifications: NutraceuticsRx Siberian Rhodiola
Rosea extract is characterized to
contain more than 3% rosavins (rosavin, rosarin and rosin) and 1% salidroside,
analyzed by HPLC . Our ProfileProven system is designed to confirm the
botanical identity of each extract by HPLC fingerprint analysis. The contents of
rosavins and salidroside will be calculated based on peak area comparison with
reference standard. Good Manufacturing Practice (GMP) and standardization of
active the principals of products ensure that all batches meet specifications.
Certificate of Analysis / Technical Specification .PDF